Persons ‘never treated’ in mass drug administration for lymphatic filariasis: identifying programmatic and research needs from a series of research review meetings 2020–2021

Risk factors for lymphatic filariasis and mass drug administration non-participation in Mandalay Region, Myanmar

(2021) Benjamin F. R. Dickson et al.   Parasites & Vectors

Assessing factors influencing communities’ acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana

(2021) Reza A. Niles et al.   PLoS Neglected Tropical Diseases

Proxy Responses for Mass Drug Administration Coverage Surveys: The Trends and Biases When Others are Allowed to Respond

(2021) Rini Jose et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Single-Dose Triple-Drug Therapy for Wuchereria bancrofti — 5-Year Follow-up

(2020) Christopher L. King et al.   NEW ENGLAND JOURNAL OF MEDICINE

Demographic, socioeconomic and disease knowledge factors, but not population mobility, associated with lymphatic filariasis infection in adult workers in American Samoa in 2014

(2020) Patricia M. Graves et al.   Parasites & Vectors

Results from two cohort studies in Central Africa show that clearance of Wuchereria bancrofti infection after repeated rounds of mass drug administration with albendazole alone is closely linked to individual adherence

(2020) Jérémy T Campillo et al.   CLINICAL INFECTIOUS DISEASES

A community survey of coverage and adverse events following country-wide triple-drug mass drug administration for lymphatic filariasis elimination, Samoa 2018

(2020) Gabriela A. Willis et al.   PLoS Neglected Tropical Diseases

Potential strategies for strengthening surveillance of lymphatic filariasis in American Samoa after mass drug administration: Reducing ‘number needed to test’ by targeting older age groups, hotspots, and household members of infected persons

(2020) Colleen L. Lau et al.   PLoS Neglected Tropical Diseases

Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models

(2018) Wilma A Stolk et al.   CLINICAL INFECTIOUS DISEASES

The prevalence of lymphatic filariasis infection and disease following six rounds of mass drug administration in Mandalay Region, Myanmar

(2018) Benjamin F. R. Dickson et al.   PLoS Neglected Tropical Diseases

The importance of patient compliance in repeated rounds of mass drug administration (MDA) for the elimination of intestinal helminth transmission

(2017) Sam H. Farrell et al.   Parasites & Vectors

Measuring and modelling the effects of systematic non-adherence to mass drug administration

(2017) Louise Dyson et al.   Epidemics

Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review

(2016) Kathryn V. Shuford et al.   Parasites & Vectors

Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two ‘Endgame’ Districts in Indonesia Using Micronarrative Surveys

(2016) Alison Krentel et al.   PLoS Neglected Tropical Diseases

‘Compliance’ versus ‘adherence’ in sport injury prevention: why definition matters

(2015) Carly D McKay et al.   BRITISH JOURNAL OF SPORTS MEDICINE

A Review of Factors That Influence Individual Compliance with Mass Drug Administration for Elimination of Lymphatic Filariasis

(2013) Alison Krentel et al.   PLoS Neglected Tropical Diseases

Preventive chemotherapy in human helminthiasis: theoretical and operational aspects

(2011) A.-F. Gabrielli et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

A Community-Based Study of Factors Associated with Continuing Transmission of Lymphatic Filariasis in Leogane, Haiti

(2010) Alexis Boyd et al.   PLoS Neglected Tropical Diseases

Assessing the Impact of a Missed Mass Drug Administration in Haiti

(2009) Kimberly Y. Won et al.   PLoS Neglected Tropical Diseases